栓塞对节段性及散发性脊髓动静脉畸形临床结局的影响:216例分析
本研究回顾性纳入216例接受栓塞治疗的硬膜内脊髓动静脉畸形患者,其中62例为脊髓动静脉节段综合征(SAMS),154例为非SAMS。结果显示,SAMS组临床和血管造影恶化风险显著高于非SAMS组,但出血事件风险两组相当;SAMS组实现≥75%栓塞闭塞可降低临床风险至与非SAMS组相当。
要点
- SAMS患者栓塞后临床和血管造影恶化风险仍高于非SAMS患者。
- SAMS栓塞后出血事件风险与非SAMS组相当。
- SAMS实现≥75%栓塞闭塞可降低临床恶化风险。
核心结论
- 栓塞使SAMS出血事件风险降至与非SAMS组相当,但SAMS临床和血管造影恶化风险仍高于非SAMS。
- SAMS实现≥75%闭塞可缓解临床风险。
研究设计与样本
- 回顾性研究纳入216例硬膜内SCAVM接受栓塞治疗的患者,其中SAMS组62例,非SAMS组154例。
- 分析初始栓塞后观察期内的临床恶化、出血事件和血管造影恶化。
主要发现
- 总体中位观察期44个月(IQR 1-307)。
关键数值与推荐
- 栓塞闭塞程度按最终闭塞率≥75%或<75%分组。
- SAMS组实现≥75%闭塞后风险与非SAMS组相当。
临床怎么用
- 对SAMS患者栓塞治疗应争取实现≥75%闭塞以降低临床恶化风险。
- SAMS患者栓塞后仍需密切监测临床和血管造影恶化。
局限性
- 回顾性研究设计。
- 样本量有限(SAMS组62例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Spinal arteriovenous metameric syndrome (SAMS) is a rare, complex vascular disorder characterized by multifocal spinal cord arteriovenous malformations (SCAVMs) affecting structures derived from the same metameric segment. The long-term clinical outcome of SAMS, particularly after embolization, remains poorly understood. This study evaluated the clinical outcomes of embolization for SAMS compared with nonmetameric SCAVMs. METHODS: This retrospective study included 216 patients with intradural SCAVMs who underwent embolization (62 patients with SAMS and 154 patients without metameric background [non-SAMS group]). Clinical and imaging data were reviewed to assess clinical worsening, hemorrhagic events, and angiographic worsening during the observation period after initial embolization. RESULTS: The overall median observation period was 44 months (IQR, 1-307). The SAMS group was associated with a higher risk of clinical and angiographic worsening compared with the non-SAMS group (hazard ratio [HR] 2.90; 95% CI 1.37-6.12; P = .0003, and HR 5.04; 95% CI 2.03-12.50; P = .0001). Regarding hemorrhagic events, the SAMS group demonstrated a risk equivalent to the non-SAMS group (HR 1.93; 95% CI 0.65-5.78; P = .234). In subgroup analysis based on final occlusion rate (≥75% or <75%) of intradural SCAVMs, failure to achieve ≥75% occlusion in the SAMS group resulted in significantly worse clinical and angiographic outcomes (HR 5.28; 95% CI 1.90-14.66; P = .001, and HR 9.41; 95% CI 3.02-29.34; P = .0001). Achieving ≥75% occlusion resulted in a risk comparable with that of the non-SAMS group. CONCLUSION: Embolization reduced the risk of hemorrhagic events in SAMS to a level comparable with the non-SAMS group. However, SAMS carries a higher risk of clinical and angiographic worsening than non-SAMS, even after embolization. Achieving sufficient occlusion (≥75% occlusion) of intradural SCAVMs mitigates these clinical risks in SAMS.
引用
- Ryu B, Consoli A, Sgreccia A, et al. Impact of Embolization on Clinical Outcomes After Treatment of Metameric and Sporadic Spinal Cord Arteriovenous Malformations: An Analysis of 216 Patients. Neurosurgery. 2026. PMID: 41983682. doi:10.1227/neu.0000000000004028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。